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Abstract
Background: Dengue resurged in Singapore during 2013-14, causing an outbreak with unprecedented number of
cases in the country. In the present study, we summarise the epidemiological, virological and entomological
findings gathered through the dengue surveillance programme and highlight the drivers of the epidemic. We
also describe how the surveillance system facilitated the preparedness to moderate epidemic transmission of
dengue in the country.
Methods: The case surveillance was based on a mandatory notification system that requires all medical practitioners
to report clinically-suspected and laboratory-confirmed cases within 24 hours. The circulating Dengue virus (DENV)
populations were monitored through an island wide virus surveillance programme aimed at determining the serotypes
and genotypes of circulating virus strains. Entomological surveillance included adult Aedes surveillance as well as
premise checks for larval breeding.
Results: A switch in the dominant serotype from DENV-2 to DENV-1 in March 2013 signalled a potential spike in cases,
and the alert was corroborated by an increase in average Aedes house index. The alert triggered preparedness and
early response to moderate the impending outbreak. The two-year outbreak led to 22,170 cases in 2013 and 18,338 in
2014, corresponding to an incidence rate of 410.6 and 335.0 per 100,000 population, respectively. DENV-1 was the
dominant serotype in 2013 (61.7 %, n = 5,071) and 2014 (79.2 %, n = 5,226), contributed largely by a newly-introduced
DENV-1 genotype III strain. The percentage of houses with Ae. aegypti breeding increased significantly (p < 0.001) from
2012 (annual average of 0.07 %) to 2013 (annual average of 0.14 %), followed by a drop in 2014 (annual average of 0.
10 %). Aedes breeding data further showed a wide spread distribution of Ae. aegypti in the country that corresponded
with the dengue case distribution pattern in 2013 and 2014. The adult Aedes data from 34 gravitrap sentinel sites
revealed that approximately 1/3 of the monitored sites remained at high risk of DENV transmission in 2013.
Conclusions: The culmination of the latest epidemic is likely to be due to a number of demographic, social, virological,
entomological, immunological, climatic and ecological factors that contribute to DENV transmission. A multi-pronged
approach backed by the epidemiological, virological and entomological understanding paved way to moderate the
case burden through an integrated vector management approach.
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Background
Dengue fever is currently the most prevalent mosquito-
borne viral disease, especially in the Americas and Asia,
caused by Dengue virus (DENV) which is transmitted to
humans primarily by Aedes aegypti and Ae. albopictus
mosquitoes [1, 2]. DENV is a positive sense single
stranded enveloped RNA virus of the genus Flavivirus
[3]. Its genome is approximately 11.8 kb in size, and en-
codes for a single polypeptide flanked by highly struc-
tured 5’ and 3’ untranslated regions. DENV exists in
four phylogenetically and antigenically distinct serotypes
(DENV1-4) and exposure to a particular serotype elicits
type-specific life-long immunity [4]. The virus is further
subdivided into genotypes based on envelope (E) gene
and envelope/non-structural protein 1 (E/NS1) gene
junction regions [5, 6]. These genotypes show a charac-
teristic geographical distribution [7], implying a com-
petitive advantage for individual genotypes that differ in
their ability to spread and cause disease in a particular
region.
DENV infection causes a clinical syndrome that is pri-
marily benign, but can seldom be fatal due to increased
vascular permeability, leading to systemic shock and
multi-organ failure [8]. It is estimated to affect approxi-
mately 50–200 million individuals each year. More than
125 countries distributed across Americas, Southeast
Asia and the Western Pacific regions are endemic to
DENV, where almost 50 % of the world population lives
at risk [1, 9]. The magnitude of dengue incidence has
increased by 30-fold in the past five decades, mainly
contributed by rapid urbanization, overcrowding, in-
creased global travel and expansion of vector popula-
tions. Except for the tetravalent vaccine (Dengvaxia®)
approved recently in a few countries, there is neither an
effective antiviral agent nor a licensed vaccine against
DENV in many endemic settings where vector control
remains as the sole strategy for epidemic control and
prevention of dengue.
Dengue fever replaced malaria as the most important
mosquito-borne disease in Singapore in the mid-1960s.
As a result, a nationwide integrated Aedes mosquito
control programme was introduced at that time to sup-
press the vector population and thereby DENV trans-
mission in the country. The programme primarily
focused on vector source reduction through surveillance,
enforcement, community engagement, careful urban plan-
ning and operational research. Consequently, the Aedes
house index was successfully brought down from about
50 % in 1960s to less than 5 % by the late 1970s. This re-
sulted in a corresponding decline in dengue incidence
[10–13]. However, dengue fever started to resurge in the
country in 1980s, in a typical 5–6 year epidemic cycle.
The magnitude of epidemics escalated within each cycle
during the last decade, despite maintaining a consistently
low Aedes house index (below 1 %) [14–16]. It has been
postulated that the resurgence is due to multiple factors
that facilitate DENV transmission: an increase in hu-
man population density, low herd immunity resulting
from long periods of low transmission [17–20], im-
proved local transportation that facilitates virus dissem-
ination, increased travel-related virus importations and
the geo-expansion of Ae. aegypti in parallel to urban
developments. It could also be partly due to improved
diagnostic and notification rates over the years. These
changing epidemiological settings signaled a need for a
strategic revision of the integrated Aedes mosquito con-
trol programme. Based on programme reviews in the
last decade, an enhanced approach for dengue control
organised around three key approaches; inter-epidemic
surveillance and control, risk based prevention and
intervention as well as coordinated intersectoral co-
operation, has been introduced. The current integrated
surveillance framework is supported by four main pil-
lars; 1). Improved operational response through en-
hanced case surveillance by using rapid diagnostics; 2).
Early warning of outbreaks based on virus surveillance;
3). Understanding the distribution of vectors and their
density fluctuations through entomological surveillance;
4). Understanding the relationship between environ-
mental parameters and outbreak risk. Currently, all four
serotypes of DENV circulate in Singapore [21] where
one serotype is typically dominated for a particular
period until it is replaced by another serotype. Such
“serotype switch” events have preceded previous epi-
demics [15]. A switch from DENV-2 to DENV-1 in
early 2004 was associated with an outbreak during
2004-2005. In early 2007, DENV-2 gained dominance
from DENV-1 and drove the 2007-08 epidemic of over
8,000 cases [15]. Dengue incidence stabilized subse-
quently around an annual figure of 5,000 cases until the
end of 2012. Singapore experienced yet another unpre-
cedented increase in dengue cases in 2013 and 2014,
recording 22,170 and 18,338 cases, respectively [22].
In the present study, we present an account of the re-
surgence of dengue fever in Singapore during 2013-14,
the worst known dengue fever encounter in the country.
We describe how the surveillance system led to an early
warning of the outbreak, and how it facilitated prepared-
ness within the country. We also present the virological
and entomological findings gathered through the surveil-
lance programme.
Results
Early warning of an impending outbreak
In March 2013, the proportion of DENV-1 rose from
20–30 % to more than 50 %, replacing DENV-2 as the
predominant serotype. The switch in predominant sero-
type signaled a potential spike in cases in the approaching
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“dengue season” during May-August. The alert was fur-
ther corroborated by the earlier than usual escalation of
weekly cases at the beginning of 2013, and an increase
in average Aedes house index from 0.17 (range: 0.12–
0.27) in 2012 to 0.19 (range: 0.11–0.25) in 2013. In epi-
demiological week 9 (March 2013), a newly-developed
statistical model [23] provided a forecast of about 800
cases per week at the peak of the epidemic in June. The
temporal model utilizes data obtained through case and
vector surveillance as well as weather parameters [23].
Based on the multiple warning signs, the National En-
vironment Agency (NEA) enhanced its vector control
in the community and initiated preparation to respond
to the outbreak. All stakeholders were also warned
through the Inter-Agency Dengue Task Force [14] of the
impending epidemic risk. The community was galvanized
through a campaign in April 2013.
Epidemiological findings
The epidemic took off in January 2013 (week 1–5) and
weekly cases showed a rapid surge in April (week 14–
18) to reach the first peak in June 2013 (week 23–26)
(Fig. 1). There were 134 cases in the first week of
January 2013, which escalated to reach 842 cases in
25th week. The trend declined and stabilized between
September 2013 (week 36–39) and January 2014 (week
1–5). The second peak was observed in July 2014,
reaching 891 cases in 27th week, the highest weekly
number of dengue cases ever recorded in Singapore.
The epidemic started to subside in November 2014
(week 45–48), recording the lowest number of weekly
cases in 47th week (n = 149).
The total number of laboratory-confirmed cases re-
ported in 2013 (n = 22,170) and 2014 (n = 18,338) corre-
sponded to an incidence rate of 410.6 and 335.0 per
100,000 population, respectively. The incidence rate in
2013 was the highest reported so far in Singapore and
exceeded the previous highest recorded in 2005 (333.1
per 100,000 population, n = 14,210). The diagnostic rate at
Environmental Health Institute (EHI) diagnostics surged
from 27 % (n = 86) of the total number of samples tested
in January 2013 to 41 % (n = 139) in March, 12 weeks
ahead of the first peak (Fig. 1). The rate dropped gradually
and maintained between 20–30 % from July 2013 to reach
the lowest (15 %) in February 2014. An upward momen-
tum occurred subsequently to reach the peak diagnostic
rate (46 %) in April followed by another peak (49 %) in
July 2014. The second peak coincided with the highest
number of weekly cases in 2014. The relationship between
the EHI diagnostic rate and total number of reported
cases from 2012 to 2014 showed a positive correlation
(Spearman’s correlation =0.73, P < 0.05).
Virological findings
DENV serotypes were confirmed in 8,216 samples in
2013 and 6,598 samples in 2014, which corresponded to
37.1 and 36.0 % coverage of all dengue cases reported in
respective years. These viruses also included 45 and 12
specimens of Ae. aegypti and Ae. albopictus collected in
2013 and 2014, respectively. In 2013, the overall serotype
composition was dominated by DENV-1 (61.7 %, n =
5,071), followed by DENV-2 (24.8 %, n = 2,034), DENV-3
(11.5 %, n = 941) and DENV-4 (2.0 %, n = 170). The
trend continued in 2014; DENV-1 (79.2 %, n = 5,226),
DENV-2 (18.1 %, n = 1,194), DENV-3 (2.5 %, n = 165)
and DENV-4 (0.2 %, n = 13). As shown in Fig. 2, the
serotype composition was more diverse in 2013, espe-
cially during the first half of the year, than in 2014, sug-
gesting that a mixed viral population circulated during
the early epidemic establishment period.
A total of 1,270 complete E gene sequences was gener-
ated in 2013 (Table 1). The corresponding number for
2014 was 1,531. The sequence collection included 38
mosquito-derived virus sequences in 2013 and another
six sequences detected among mosquitoes trapped in
2014. The overall genotype coverage was 4.5 % and 8.4 %
Fig. 1 Epidemiological curve for weekly dengue cases in 2013 and 2014. All cases are laboratory confirmed
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of all reported cases in 2013 and 2014, respectively. The
majority (60.6 %, n = 770) of virus strains sequenced in
2013 were DENV-1, followed by DENV-2 (26.1 %, n =
332) (Table 1). Similarly, DENV-1 and DENV-2 consti-
tuted 75 % (n = 1150) and 21.8 % (n = 334) of genotyped
samples in 2014, respectively. The proportion of DENV-3
sequences generated in 2013 (n = 133, 10.5 %) was 3.6
times higher than that in 2014 (n = 43, 2.9 %).
Phylogenetic analysis revealed that DENV-1 genotype
III was the dominant genotype among all four serotypes
sequenced in 2013 (n = 666, 52.4 %) and 2014 (n =
1,010, 65.9 %). This “epidemic strain” was first detected
in a sporadic case in November 2012, at a time when
DENV-2 cosmopolitan genotype was leading the trans-
mission. In January 2013, the epidemic strain of DENV-
1 genotype III was detected in a major dengue cluster
in the Southeastern part of Singapore, indicating the es-
tablishment of indigenous transmission of this strain. It
took the lead from DENV-2 cosmopolitan genotype in
March 2013 and continued to expand throughout the
country. The epidemic strains showed a rapid accumu-
lation rate (Fig. 3) and formed a lineage distinct from
those reported earlier locally [21], with 99 % bootstrap
support (Fig. 4a). This genetic distinction of the epi-
demic lineage suggested that its appearance in the
country was due to an introduction. Its closest relatives
were DENV-1 genotype III strains reported from India,
Bangladesh and China during 2008-2011 periods
(Fig. 4a), indicating the circulation of genetically-
related virus strains in Asia preceding the epidemic and
thereby the likelihood of its introduction from a re-
gional country.
In addition, the early establishment phase of the epi-
demic saw an uprising of two new strains: DENV-2
cosmopolitan genotype clade I (named as clade Ia) and
DENV-3 genotype III (Fig. 4a and b). Both strains
formed genetically distinct clusters in respective phylog-
enies (Fig. 4a and b) and were likely to be newly intro-
duced. Clade Ia shared ancestry with DENV-2 strains
reported earlier from Indonesia during 2010-2012 pe-
riods, whereas DENV-3 genotype III strains were related
to those reported from India during 2009-2010 periods.
The first evidence of DENV-2 cosmopolitan clade Ia in
Fig. 2 Weekly distribution of DENV serotypes in Singapore: 2013-2014. The serotype proportions were calculated based on 14,814 patient sera
successfully typed in 2013 (n = 8,216) and 2014 (n = 6,598)
Table 1 Composition of DENV genotypes circulated during the
epidemic in 2013 and 2014
Serotype Genotypes/clades 2013 2014
DENV-1 Genotype I 97 (7.6 %) 136 (8.9 %)
Genotype II 04 (0.3 %) 0 (0 %)
Genotype IIIa 669 (52.7 %) 1,014 (66.2 %)
DENV-2 Asian I 0 (0 %) 01 (0.1 %)
Cosmopolitan 02 (0.2 %) 12 (0.8 %)
Cosmopolitan Clade I 28 (2.2 %) 11 (0.7 %)
Cosmopolitan Clade 1a 151 (11.9 %) 13 (0.8 %)
Cosmopolitan Clade 1b 33 (2.6 %) 269 (17.6 %)
Cosmopolitan Clade III 74 (5.8 %) 0 (0 %)
Cosmopolitan Clade V 12 (0.9 %) 0 (0 %)
Cosmopolitan Indian 32 (2.5 %) 28 (1.8 %)
DENV-3 Genotype I 02 (0.2 %) 26 (1.7 %)
Genotype II 03 (0.2 %) 01 (0.1 %)
Genotype III 128 (10.1 %) 16 (1 %)
DENV-4 Genotype I 01 (0.1 %) 01 (0.1 %)
Genotype II 34 (2.7 %) 03 (0.2 %)
Total 1,270 1,531
aincludes epidemic strains in 2013 (n = 666) and 2014 (n = 1,010)
The proportion of each genotype among all genotyped cases for the
respective year is shown within brackets. The phylogeny of genotypes and
clades of DENV serotypes is given in Fig. 4a and b
Hapuarachchi et al. BMC Infectious Diseases  (2016) 16:300 Page 4 of 13
Singapore was in June 2012 (23rd week). Prior to the set-
ting out of the epidemic, clade Ia strains maintained a
low profile, but showed a rapid surge in case accumula-
tion from January 2013 and started to subside at the end
of the year. There were only 30 clade Ia strains in 2012,
whereas 151 sequences were generated in 2013. On the
other hand, DENV-3 genotype III strains emerged in
January 2013, at the beginning of the epidemic. Its circu-
lation lasted until 42nd week of 2013. These observations
suggested that prevailing favourable conditions for virus
transmission during the early phase of the epidemic
allowed multiple newly-introduced virus strains to pro-
liferate and spread.
As summarised in Table 1, besides the major strains
described above, multiple virus strains belonging to all
four DENV serotypes circulated during the epidemic
period. The phylogeny representative of all these strains
has been illustrated under respective serotypes (Fig. 4a
and b). The temporal fluctuation of proportions of each
strain among all genotyped cases demonstrated a highly
heterogeneous DENV population at any given time,
though a few strains were dominant. Those dominant
strains were widely distributed across the country, and
contributed to 70–80 % of cases during 2013-14. On the
other hand, the “minor” strains were less well established
and their transmission was generally localized. One of
the notable observations was that a relatively higher
number of genetically distinct strains, including “minor”
strains, circulated in substantial proportions in 2013
than in 2014 (Table 1). Besides the availability of a sus-
ceptible human pool, the sustainability of vector-borne
virus transmission is affected by the vector density.
When the mosquito population size is small, the domin-
ant strains are likely to saturate the infectious mosquito
pool relatively fast, leaving little opportunity for “minor”
strains to settle down. On the other hand, when the
mosquito population expands, especially during peak pe-
riods of transmission, the chances for more virus strains
to establish transmission also increase. As the control
measures are targeted to suppress the Aedes population,
their numbers fluctuate and virus populations are ex-
pected to go through bottlenecks during periods of low
Aedes density. Importantly, the vector density fluctua-
tions are not universal across the country as areas with
higher number of disease clusters, especially major clus-
ters, require more effort and time to bring down the
mosquito density than in areas with localized transmis-
sion. Consequently, the effects of vector control efforts
are more likely to be profound on the “minor” strains
that show localized transmission than dominant strains.
These findings suggested that favourable conditions for
virus transmission prevailed in 2013, but sustained disease
control measures may have facilitated the elimination of
many DENV strains in 2014. It is noteworthy that immune
pressure and evolutionary forces may also have affected
the survival of virus strains and may have contributed to
fluctuations in virus population independent of vector
density.
Nevertheless, disappearance of major strains provided
the opportunity for less-common strains to dominate.
One such example is the replacement of DENV-2
cosmopolitan clade Ia by clade Ib strains in April 2014.
Clade Ib has been circulating since February 2013, but
was unable to dominate over clade Ia until the latter
Fig. 3 Cumulative dynamics of cases due to the most common DENV strains detected during the epidemic and their case contributory pattern
in 2013 and 2014. The weekly national serotype data and weekly EHI genotype data from 2007 to 2014 were used to estimate the historical
genotype proportions. In order to obtain smooth estimates of genotype proportions over time, a Bayesian approach was used assuming multinomial
distribution of serotypes and genotypes, and an auto-correlated prior distribution for logarithm transformed proportions. Bayesian estimates of the
weekly genotype proportions were sampled from the posterior distribution, which were used together with weekly national case count to calculate
the weekly cases attributed to each genotype as well the cumulative case count. The analysis was done using R software version 3.1.1 [33]. Only the
genotypes dominant during the epidemic years have been plotted in the graph
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became gradually extinct in early 2014. Interestingly,
clade Ib was the dominant strain circulated in Johor and
Melaka, the southern states of Malaysia, in 2013 [22].
Johor is the closest Malaysian state to Singapore. The
detection of identical clade Ib strains in Singapore indi-
cated the possibility of virus exchange between the two
countries [22]. Clade Ib’s dominance in Malaysian states
also suggested its outbreak potential. In fact, clade Ib
has been the dominant DENV-2 strain in Singapore
since May 2014.
Entomological findings
The house index for Aedes mosquitoes in three main
types of residential premises, namely government-
sponsored Housing Development Board (HDB) flats,
private apartments and condominiums as well as
landed properties, increased gradually from the end of
September 2012 (Fig. 5). The increase was most obvi-
ous in HDB and landed properties categories. Among
the Aedes immatures collected, the proportion of Ae.
aegypti mosquito breeding, the primary vector of
DENV in Singapore, in residential premises was 59.5
and 54.6 % in 2013 and 2014, respectively.
The percentage of houses with Ae. aegypti mosquito
breeding (named as Ae. aegypti house index) was signifi-
cantly higher (p < 0.001) in 2013 (annual average of 0.14)
than in 2012 (annual average of 0.07). The index reached
its peak at the beginning of the inclination of cases in Feb-
ruary 2013 (Fig. 6). The trend continued in 2014 though
at a lower magnitude (annual average of 0.10) than in
2013 (Fig. 6). Moreover, the distribution of Ae. aegypti ex-
panded dramatically during the decade from 2003 to 2013
in parallel to infrastructure development in the country
(Fig. 7a). The new areas generally represented newly-
developed urban residential sites that are mainly distrib-
uted in south-central and western parts of Singapore
(Fig. 7a). As expected, the dengue case distribution pattern
in 2013 and 2014 was in line with the geographical spread
of Ae. aegypti in the country (Fig. 7b).
In the third quarter of 2013, an adult Aedes sentinel
surveillance system was established with about 3,000
Gravitraps in 34 locations throughout the island, in
addition to Gravitraps that were deployed in ad hoc
cluster management [24]. The surveillance showed that
the average Gravitrap aegypti index, which expresses the
percentage of Gravitraps that caught at least one adult
Ae. aeygpti in a particular location, was 9.7 % (±0.3 %
SE) in 2013. The index declined to 6.2 % (±0.1 % SE) in
2014. Furthermore, the index indicated that 29.4 % of
(See figure on previous page.)
Fig. 4 E-gene based phylogeny of DENV illustrating different types of virus strains circulated during 2013-2014. Phylogenetic analysis was
performed in MEGA6 program [32] using the maximum-likelihood method based on the general time reversible model with gamma distribution and
invariant sites. The robustness of the original tree was tested with 1000 bootstrap replications. a. DENV-1 and DENV-2 strains circulated in Singapore in
both years have been highlighted in red and blue respectively. b. DENV-3 and DENV-4 strains circulated in Singapore in both years have been
highlighted in green and purple respectively. The major groups summarized in Table 1 are shown in triangular cartoons. Each taxon is named
with sample ID/NCBI accession number, reported year, country and genotype information. Numbers on branches are bootstrap support values.
GI, GII, and GIII = genotypes I, II and III; cosmo = cosmopolitan genotype
Fig. 5 Temporal variation of House Index in different types of
residential premises in 2013 and 2014. a. Housing Development Board
(HDB) apartments, b. Private apartments/condominiums and c. Landed
properties. House Index for each residential premise type is defined as
the number of houses detected with Aedes mosquito breeding per
100 houses inspected. The analysis is based on the outcome of routine
inspections carried out by approximately 800 ground officers from the
Environmental Public Health Operations, NEA. Aedes immatures
were morphologically identified to the species level at EHI.
E-week = epidemiological week
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Fig. 6 Weekly trends of cases and Ae. aegypti house index during 2012-2014. The Ae. aegypti house index is expressed as the percentage of
houses with Ae. aegypti mosquito breeding. The comparison shows that the fluctuation of Ae. aegypti house index generally preceded that
of cases
Fig. 7 Spatial distribution of Ae. aegypti and dengue cases in 2013 and 2014. a. Spatial expansion of Ae. aegypti breeding in 2013 as compared to
2003. The breeding sites were identified based on island wide Aedes breeding data collected on a daily basis as part of vector control operations.
The map was generated using the ArcGIS 10.1 ArcMap software (ESRI, CA, USA). b. Spatial distribution of dengue cases in 2013 and 2014. The
spatial distribution of dengue cases in Singapore was generated using the kernel density tool in the spatial analyst toolbox of ArcGIS 10.1 ArcMap
software (ESRI, CA, USA) based on a search radius of 400 m. Case density values were classified into four classes of < 25th (2 cases/km2), 25th-50th
(16-25 cases/km2), 51st-75th (56-61 cases/km2) and more than 75th (217 cases/km2) quantiles, using the quantile classification method and were
displayed in tones of pink as shown in the legend
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locations (10 of 34) were at high risk of transmission
(index ≥ 12.0 % based on unpublished data, EHI) in 2013
and declined to 8.8 % (3 of 34) in 2014.
Discussion
Drivers of the epidemic
Case burden of the dengue epidemic in 2013 and 2014
was unprecedented, recording 1.7 times more cases than
those reported during the last DENV-1 epidemic during
2004-05. The culmination of the latest epidemic is likely
to be due to a number of demographic, social, viro-
logical, entomological, immunological, climatic and eco-
logical factors that contribute to DENV transmission.
The most obvious driving force of the epidemic was
emergence of a new strain of DENV-1 genotype III. In
average, this epidemic strain contributed to 68.5 % of
cases among all genotyped cases (n = 2,803) during the
2013-14 periods. Serotype data that provided even a
higher coverage of reported cases (an average of 36.6 %
in both years) confirmed the dominance of DENV-1
during the same period (in average, 69.5 % of serotyped
cases). The peak of the epidemic during May-June 2013
was preceded by a change in the dominant serotype
from DENV-2 to DENV-1, approximately four months
after the first evidence of epidemic strains in November
2012. A similar event has occurred in Singapore during
a dengue epidemic during 2007-08, which anchored the
phenomenon of “serotype switch” as a warning sign of
epidemic risk in the country [15].
Besides highly-potential virus strains, the epidemic
transmission of DENV requires the connectivity be-
tween two important contributors: a susceptible human
population and an optimal vector density. The latter is
partially affected by climatic and ecological factors.
Once exposed to a particular serotype of DENV, an in-
dividual elicits type-specific life-long immunity, but re-
mains immunologically susceptible to a heterotypic
DENV infection [4]. Therefore, the long term absence
or low prevalence of a particular serotype in an area
increases the proportion of population susceptible to
infections by the respective serotype. This may explain
the dominant emergence of DENV-1 after eight years
in Singapore. The last DENV-1 epidemic in the country
was in 2005 [14]. The lower prevalence of antibodies
reactive to DENV-1 than that of DENV-2 across mul-
tiple age groups in a cross-sectional study among
healthy individuals aged 16–60 years during 2009-10
also testified that a higher proportion of individuals, es-
pecially those within the age group of 16–30 years, re-
mains susceptible to DENV-1 than DENV-2 [20].
Furthermore, the seroprevalence data suggests that
strict disease control measures since early 1970’s have
widened the susceptible age range by reducing the risk
of virus exposure. There has been a gradual reduction in
dengue seropositivity from 1982 to 2009 across all age
groups [20]. The age-standardized seroprevalence in
adults aged 18–79 years dropped from 63.1 % in 2004 to
54.4 % in 2010 [17]. Importantly, the sharpest reduction
in seropositivity was seen in less than 20 years old age
group, indicating the low level of exposure to dengue
among young generations. The overall seroprevalence
among individuals aged 16–25 years was 16.1 % during
2009-10 periods [20]. Moreover, the rapid growth of
non-resident population (from 19 % in 2005 to 29 % in
2014) in the country due to its reliance on foreign labor
is also likely to have contributed to the expansion of sus-
ceptible proportion. However, recent data demonstrating
a reducing trend of seroprevalence among Singapore
resident population [20] and a low level (0.01; 95 % CI:
0.0085–0.012) of the force of infection since 1993 (un-
published data, EHI) suggests that the gradual increase
in magnitude of dengue case burden could partially be
contributed by the improved rate of case detection in re-
cent years.
The entomological surveillance data indicated an in-
crease in both larval and adult Ae. aegypti population
during the epidemic period. The average percentage of
houses with Ae. aegypti mosquito breeding doubled in
2013 as compared to 2012. Moreover, the data sug-
gested Ae. aegypti breeding in a high proportion of resi-
dential premises in the latest epidemic years. Aedes
aegypti adult surveillance with Gravitraps also demon-
strated high vector density in many locations prior to
and during the epidemic. These observations supported
the notion that prevailing vector and host factors were
favourable for virus transmission at the time of intro-
duction of a new virus lineage and explained its rapid
establishment and spread across the island. The ground
conditions were conducive to sustain virus transmission
on a longer term causing an unprecedented epidemic.
Epidemic response
In Singapore, the control of vector-borne diseases, in-
cluding dengue, is carried out by NEA, and the clinical
management and surveillance is overseen by the Minis-
try of Health (MOH) [25]. The close coordination be-
tween the two sectors is therefore imperative to tackle
vector-borne diseases. While surveillance of vector-
borne diseases rides on the national disease surveillance
programme at MOH, daily communication of surveil-
lance data enables prompt vector control response by
NEA. Therefore, several activities were jointly initiated
by the MOH and NEA to manage the epidemic crisis.
1). Enhanced case surveillance measures to increase
the diagnostic coverage and to enable prompt vector con-
trol response. Due to the unprecedented increase in cases
during the early phase of the epidemic, the medical
community was appraised through MOH to have a high
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clinical suspicion of dengue among febrile cases. More-
over, an existing network of general practitioners was
encouraged to utilize a subsidized laboratory testing ser-
vice provided by EHI, one of the public health laborator-
ies under NEA, Singapore.
2). Projection of case numbers to facilitate stockpiling
of diagnostic reagents and to accommodate increased de-
mand on the healthcare system. Based on the statistical
model projection on weekly case numbers [23], arrange-
ments were made to extend EHI diagnostic services dur-
ing weekends and to stockpile diagnostic reagents
several months ahead of the peak of the epidemic. The
close communication between MOH and NEA on the
weekly case projection also allowed hospitals to plan for
increased demand on the healthcare system resulting
from extra consultations and admissions.
3). Expansion of virus surveillance activities to facili-
tate the resource allocation for targeted vector control. In
order to achieve a better serotype and genotype coverage
during the epidemic, the existing virus surveillance
programme at EHI [15, 21] was extended to include
samples from polyclinics, hospitals and private labora-
tories through a joint initiative between NEA and MOH.
During non-epidemic periods, the programme generally
screens a relatively small proportion of reported cases
received through an island wide general practitioner net-
work as an assessment of impending epidemic risk [15,
21]. Consequently, serotype analysis was completed in
more than 1/3 of total reported cases and the genotype
coverage was doubled from 2013 to 2014. Assisted by
geographical information system (GIS)-based plotting of
patients’ residential locations, the serotype and genotype
data provided a detailed understanding of the spatial and
temporal distribution of virus strains within the country.
Genetic fingerprinting of virus strains allowed monitor-
ing of their spread between locations and facilitated tar-
geted vector control in newly-introduced sites. The same
approach was used to monitor the successful elimination
of virus transmission in disease clusters.
4). Early launch of the dengue campaign to promote
community awareness of dengue situation and prevention
of transmission. As the epidemic was looming, NEA
brought forward the launch of “Do the Mozzie Wipeout”
campaign to April in 2013. The campaign, which is usu-
ally launched at the beginning of “dengue season” in the
middle of each year, is part of the community outreach
programme aimed at promoting awareness of dengue
situation and inspiring action to prevent dengue. A
colour-coded alert system was also launched through
the Dengue Community Alert System to keep residents
informed about active disease clusters in respective lo-
calities. The banners coded green (no dengue clusters),
yellow (dengue cluster with < 10 cases) and red (dengue
cluster with ≥ 10 cases) were displayed to indicate the
seriousness of dengue situation in each vicinity. More
than 400 individuals were trained as “dengue volunteers”
in order to support the community outreach activities
that continued throughout the epidemic through semi-
nars, talks, roadshows and media.
5). Enhanced source reduction for mosquito breeding
through an accelerated premise inspection programme.
The entomological surveillance and enforcement activ-
ities were also carried out in parallel. House-to-house
checks were conducted by about 800 ground officers
who targeted to check every home and surrounding
areas for mosquito breeding. Apart from homes, daily
checks also cover common ground areas, public areas
and congregation areas for potential mosquito breeding
spots. The inspection frequency was accelerated to cover
all premises within the boundary of disease clusters dur-
ing the epidemic period. A total of 8,781,935 checks was
conducted in residential houses during 2013-14. Chem-
ical larviciding activities were carried out in housing es-
tates, industrial premises and public places on a regular
basis and whenever Aedes breeding was detected
through inspections. The public was encouraged to use
pellets containing Bacillus thuringiensis in places such
as roof gutters. Fogging activities were conducted in
major clusters during the peak periods of transmission
to reduce adult Aedes population density especially when
the intensity of transmission sustained despite other
source reduction efforts. Data on Aedes immatures col-
lected through field inspections was used to gauge Aedes
population density in a particular area.
6). Launch of gravitrap surveillance to monitor the
fluctuations of adult Aedes population. The existing vec-
tor population assessment based on Aedes breeding data
was complemented by adult Aedes monitoring with
Gravitraps in disease clusters as well as in 34 sentinel
locations.
7). Guiding resource allocation for targeted vector con-
trol based on a spatial risk map. An island wide risk
map developed based on data pertaining to Aedes breed-
ing, past dengue exposure, population density, circulating
virus strains etc. was used to guide resource allocation for
targeted vector control during the epidemic.
8). Integrated vector management activities aligned
with the whole-of-government’s effort. Integrated vector
management activities in Singapore are closely aligned
with the whole-of-government’s effort in establishing
people, public and private (3P) partnership to develop
innovative and sustainable initiatives to promote envir-
onmental ownership in the community. NEA leads an
Inter-Agency Dengue Task Force [14] comprising 27
stakeholders from the 3P sectors to coordinate nation-
wide dengue control efforts. The Inter-Agency Dengue
Task Force assisted the epidemic control by ensuring the
planning and implementation of operational activities of
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each agency to align with source reduction and vector
control efforts carried out by NEA.
All those activities were aimed at gaining a clear pic-
ture of case burden and Aedes population over time in
order to monitor the intensity and the potential sustain-
ability of disease transmission. In addition to NEA’s
source reduction efforts on the ground, the control
programme relied on the community participation to
minimize human-vector contact and Aedes breeding at
residential premises. Even though it was difficult to dir-
ectly measure the impact of those activities on the dis-
ease transmission, a comparison between the weekly
trends of Aedes house index and case data showed that
cases generally fluctuated in parallel to mosquito popu-
lation variations (Fig. 6). The intense control efforts
could bring down the case burden steeply from the
peaks through the suppression of vector population
(Fig. 6).
Conclusions
The epidemic resurgence of dengue fever in Singapore in
2013 was multi-factorial. The emergence of a new strain of
DENV-1 genotype III, expansion of the susceptible human
population, favourable conditions for mosquito breeding
and a widely-distributed vector population collectively
contributed to sustain the virus transmission during the
epidemic. A multi-pronged approach backed by the epi-
demiological, virological and entomological understanding
facilitated the resource planning and community aware-
ness that paved way to moderate dengue transmission
through an integrated vector management approach.
Methods
Case data collection
It is mandatory for medical practitioners and clinical la-
boratories to notify all clinically-suspected and laboratory-
confirmed dengue cases and deaths to MOH within
24 hours of detection. The notification information in-
cluded demographic data, travel history, clinical data,
dates of onset of illness and diagnosis. Notified cases were
investigated to determine whether the infections were au-
tochthonous or imported. Patients with no travel history
to a dengue endemic area outside of Singapore within the
seven days prior to onset of illness were defined as autoch-
thonous cases. Any epidemiological link among cases was
established whenever possible. The laboratory confirm-
ation of clinically-suspected cases is achieved either
through NS1 antigen detection or viral RNA detection by
PCR [26, 27]. Only the laboratory-confirmed cases are of-
ficially reported.
Details of cases were sent promptly to NEA to deter-
mine the clustering of cases and to conduct site visits
for further investigations to aid vector control opera-
tions. A dengue cluster is defined as two or more cases
epidemiologically linked by place (residential or work-
place/school) within a radius of 150 meters and with
their onset of illnesses within a 14 day period. Informa-
tion was uploaded onto the Geographical Information
Systems (GIS) server in order to identify areas of active
dengue transmission.
Virological data collection
The circulating DENV populations were monitored
through a virus surveillance programme jointly con-
ducted by the MOH and NEA. Briefly, blood samples
from suspected dengue patients who sought treatment
at general practitioners, public/private hospitals and
polyclinics were tested for the evidence of DENV by
using either NS1 antigen or polymerase chain reaction
(PCR) assays. The serotype and genotype analyses were
performed on a weekly basis to provide a timely update
on the composition and distribution of DENV popula-
tions to facilitate the prioritizing of resource allocation
for dengue control operations. The screening also in-
cluded individual field-caught mosquitoes that were
positive for DENV NS1 antigen. Viral RNA from mos-
quitoes was extracted as described previously [28].
DENV-positive sera and mosquito specimens were fur-
ther analysed to determine the serotype of DENV by
using a real time reverse-transcription PCR (RT-PCR)
assay as described elsewhere [26]. At EHI, one of the
public health laboratories in Singapore, all DENV-
positive sera that failed serotype screening by the real
time RT-PCR assay were subjected to a modified semi-
nested conventional PCR assay [29, 30].
For the genotype surveillance, E gene of DENV was
PCR amplified and sequenced using serotype-specific
primers as described previously [29]. Nucleotide se-
quences were assembled using the Lasergene package
version 8.0 (DNASTAR Inc., Madison, WI, USA). Con-
tiguous sequences were aligned using BioEdit v7.0.5
software [31]. Phylogenetic analysis of E gene sequences
was performed in MEGA6 program [32] using the
maximum-likelihood method based on the general time
reversible model with gamma distribution and invariant
sites. The robustness of the original tree was tested
with 1000 bootstrap replications.
Entomological data collection
As part of active preventive surveillance, premise checks
for larval breeding were undertaken by approximately
800 ground officers from the Environmental Public
Health Operations, NEA, with an aim of checking every
home and surrounding areas every three to six months.
Such source reduction and vector surveillance efforts
were enhanced in vicinities with high risk of DENV
transmission, such as dengue clusters. Aedes immatures
collected by field officers were morphologically identified
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to the species level at EHI. The number and type of
breeding places as well as mosquito identification data
was recorded in a common database for operational pur-
poses. The mosquito identification data was also used
for enforcement activities. In addition, adult Aedes popu-
lation monitoring was conducted with about 3,000
Gravitraps at 34 sentinel locations weekly and within se-
lected cluster areas on ad hoc basis. The design and de-
ployment of Gravitraps have previously been described
[24]. For all adult samples collected from clusters and
sentinel locations, the abdomens of trapped Aedes mos-
quitoes were pooled into groups of five and screened for
DENV by using a Dengue NS1 antigen assay as previ-
ously described [28].
Data analysis
Incidence rates were calculated using all laboratory-
confirmed cases reported to MOH based on the estimated
mid-year population obtained from the Singapore Depart-
ment of Statistics, Ministry of Trade and Industry. The
house index and Ae. aegypti house index were calculated
based on Aedes breeding data collected by ground officers
through routine premise inspections. The Ae. aegypti
house indices from 2012 to 2014 were compared by using
the paired two sample t test in R software version 3.1.1
[33]. The Gravitrap aegypti index was calculated based on
adult Ae. aegypti data generated through the Gravitrap
sentinel system. The index expresses the percentage of
Gravitraps that caught at least one Ae. aeygpti in a par-
ticular location. The relationship between the diagnostic
rate and total number of reported cases was determined
by calculating the Spearman’s Correlation Coefficient in R
software version 3.1.1 [33]. The weekly national serotype
data and weekly EHI genotype data from 2007 to 2014
were used to estimate the historical genotype proportions.
In order to obtain smooth estimates of genotype propor-
tions over time, we used Bayesian approach, assuming
multinomial distribution of serotypes and genotypes, and
an auto-correlated prior distribution for logarithm trans-
formed proportions. We then sampled from the posterior
distribution to get the Bayesian estimates of the weekly
genotype proportions, which were used together with
weekly national case count to calculate the weekly cases
attributed to each genotype as well the cumulative case
count. The analysis was done using R software version
3.1.1 [33]. Only the genotypes dominant during the epi-
demic years have been plotted in the graph.
The spatial distribution of dengue cases in Singapore
was generated using the kernel density tool in the spatial
analyst toolbox of ArcGIS 10.1 ArcMap software (ESRI,
CA, USA) based on a search radius of 400 m. Case
density values were classified into four classes of < 25th
(2 cases/km2), 25th-50th (16-25 cases/km2), 51st-75th (56-
61 cases/km2) and more than 75th (217 cases/km2)
quantiles, using the quantile classification method, so
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